Evidence map›Paper›PMID 35203420›Full record

ArticleBiomedicines2022

Pd

Martin Vojtek, Salomé Gonçalves-Monteiro, Patrícia Šeminská, Katarína Valová, Loreto Bellón, Patrícia Dias-Pereira, Franklim Marques, Maria P M Marques, Ana L M Batista de Carvalho, Helder Mota-Filipe and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. PdJournal of medicinal chemistry · 2024
    Article
  4. Article
  5. Article
  6. Effect of PdInternational journal of molecular sciences · 2022
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Martin VojtekLAQV/REQUIMTE, Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.ORCID 0000-0002-9257-7020
Salomé Gonçalves-MonteiroLAQV/REQUIMTE, Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.ORCID 0000-0002-2583-5624
Patrícia ŠeminskáLAQV/REQUIMTE, Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Katarína ValováLAQV/REQUIMTE, Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Loreto BellónLAQV/REQUIMTE, Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Patrícia Dias-PereiraICBAS-Instituto de Ciências Biomédicas de Abel Salazar, University of Porto, 4050-313 Porto, Portugal.
Franklim MarquesClinical Analysis Unit, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Maria P M Marques"Molecular Physical-Chemistry" R&D Unit, Department of Chemistry, University of Coimbra, 3004-535 Coimbra, Portugal.ORCID 0000-0002-8391-0055
Ana L M Batista de Carvalho"Molecular Physical-Chemistry" R&D Unit, Department of Chemistry, University of Coimbra, 3004-535 Coimbra, Portugal.ORCID 0000-0003-1280-3321
Helder Mota-FilipeiMed.ULisboa, Faculty of Pharmacy, University of Lisbon, 1649-003 Lisbon, Portugal.ORCID 0000-0003-3045-2553
Isabel M P L V O FerreiraLAQV/REQUIMTE, Laboratory of Bromatology and Hydrology, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.
Carmen DinizLAQV/REQUIMTE, Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, 4050-313 Porto, Portugal.ORCID 0000-0003-4668-9360
Universidade do Porto · PTUniversity of Coimbra · PTUniversity of Lisbon · PT

Funding

Fundação para a Ciência e Tecnologia PD/BD/135460/2017Fundação para a Ciência e Tecnologia PTDC/QEQ-MED/1890/2014Fundação para a Ciência e Tecnologia UIDB/00070/2020Fundação para a Ciência e Tecnologia UIDB/QUI/50006/2020
6 · The paper itself

Abstract

Pd

Indexed as

cisplatinin vivometal complexesPd(II)-based drugstriple-negative breast cancerxenografts

Identifiers

PMID35203420
PMCPMC8869242
OpenAlexW4205317564

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.